GPhA applauds increased funds for Office of Generic Drugs

ARLINGTON, Va. A boost in funding for the Food and Drug Administration’s Office of Generic Drugs has received praise from an organization representing the country’s generic drug industry.

The Generic Pharmaceutical Association heralded the passage and signing of the 2010 Agriculture Appropriations bill, which set aside $51.5 million for the Office of Generic Drugs, a $5 million increase over last year.

“As Americans increasingly turn to generic medicines as a means to improve their health at affordable costs, this infusion of resources should help the FDA provide more timely access to generic drugs,” GPhA president and CEO Kathleen Jaeger said in a statement. “The Office of Generic Drugs has been severely under-funded for several years, and there is no doubt that the dedicated scientists and reviewers at FDA need more resources.”